Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 19 Neoplasms 11 Polycystic Ovary Syndrome 9 Neoplasm Metastasis 4 Multiple Myeloma 4 Melanoma 4 Vomiting 3 Prostatic Neoplasms 3 Leukemia, Myeloid, Acute 3 Head and Neck Neoplasms 3 Endometrial Neoplasms 3 Triple Negative Breast Neoplasms 2 Solid Tumors 2 Skin Neoplasms 2 Sarcoma 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Peripheral Nervous System Diseases 2 Ovarian Neoplasms 2 Obesity 2 Nausea 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, B-Cell 2 Leukemia 2 Insulin Resistance 2 Inflammation 2 Diabetes Mellitus 2 Colorectal Neoplasms 2 Cognitive Dysfunction 2

Interventions

Cyclophosphamide 35 Temozolomide 33 Filgrastim 26 Etoposide 26 Carboplatin 25 Vincristine 22 Cisplatin 22 Radiotherapy 20 Magnetic Resonance Spectroscopy 18 Thiotepa 14 Irinotecan 13 Granulocyte Colony-Stimulating Factor 12 Peripheral Blood Stem Cell Transplantation 11 Lomustine 11 Specimen Handling 9 Radiation 9 Melphalan 9 etoposide phosphate 8 Topotecan 8 Methotrexate 8 X-Rays 7 Platinum 7 Phantoms, Imaging 7 sonidegib 6 Biopsy 6 1,2-diaminocyclohexaneplatinum II citrate 6 sargramostim 5 palbociclib 5 Nuclear Medicine Department, Hospital 5 HhAntag691 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Medulloblastoma × Tablets × Clear all

NCT05230758 2026-05-01

Met Med Can

The Hospital for Sick Children

Phase 3 Recruiting

Medulloblastoma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡